Hermaleigh Townsley

Sheffield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

A systematic review of asymptomatic colonisation with Group A Streptococcus in lower- and middle-income countries.

A systematic review of asymptomatic colonisation with Group A Streptococcus in lower- and middle-income countries.

Journal: The Journal of infection
Published: August 02, 2025

Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses.

Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses.

Journal: The Journal of infection
Published: July 18, 2025

Efficacy and safety of pharmacological treatments in inclusion body myositis: a systematic review.

Efficacy and safety of pharmacological treatments in inclusion body myositis: a systematic review.

Journal: RMD open
Published: October 23, 2024

Chronogram: an R package for data curation and analysis of infection and vaccination cohort studies.

Chronogram: an R package for data curation and analysis of infection and vaccination cohort studies.

Journal: Bioinformatics advances
Published: June 13, 2024

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.

Journal: The Lancet. Infectious diseases
Published: April 11, 2024

SARS-CoV-2 mucosal neutralising immunity after vaccination.

SARS-CoV-2 mucosal neutralising immunity after vaccination.

Journal: The Lancet. Infectious diseases
Published: August 25, 2023

Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variants.

Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variants.

Journal: medRxiv : the preprint server for health sciences
Published: June 09, 2023

Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection.

Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection.

Journal: The Lancet. Infectious diseases
Published: April 06, 2023

Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.

Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.

Journal: PLoS biology
Published: March 25, 2023

Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London.

Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London.

Journal: Lancet (London, England)
Published: March 13, 2023

COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.

COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.

Journal: PloS one
Published: March 10, 2023

WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.

WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed.

Journal: Lancet (London, England)
Published: September 26, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026